Peripheral sensory neuropathy associated with short-term oral acitretin therapy
Related Experiment Video
Updated: Sep 27, 2026

Establishing a Mouse Model of a Pure Small Fiber Neuropathy with the Ultrapotent Agonist of Transient Receptor Potential Vanilloid Type 1
Published on: February 13, 2018
D Tsambaos1, T Sakkis, E Chroni
1Department of Dermatology, University of Patras, Greece. tsambaos@med.upatras.gr
Abstract:
A 57-year-old female patient with widespread chronic plaque psoriasis and a 32-year-old male patient with severe oral lichen planus are reported, who developed sensory symptoms in the extremities 3 and 4 months after the onset of oral acitretin therapy, respectively. Both patients showed clinical and electrophysiological evidence of a sensory peripheral neuropathy, which completely resolved 2 and 2.5 years after discontinuation of oral acitretin administration, respectively.
Related Concept Videos
Diabetic Neuropathy
Drug toxicity: Idiosyncratic Reactions
Acid Suppressive Drugs for Peptic Ulcer Disease: Antacids
However, this neutralization reaction between...
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
Chronic Kidney Disease II: Clinical Manifestations
Drug Toxicity: Allergic Reactions